ArticleBlood2015

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Chunhua Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.